Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (IMPT Study)

NCT05504135 is registered in ClinicalTrials.gov with Nalagenetics Pte Ltd as lead sponsor.

NCT NCT05504135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05504135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (IMPT Study)
Lead sponsor
Nalagenetics Pte Ltd
Phase
Observational
Overall status
Completed
Start date
October 3, 2022
Completion date
August 31, 2024
Enrollment
222 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pre-emptive pharmacogenomics